Haemonetics (HAE) announced U.S. FDA 510(k) clearance for the NexSys PCS Plasma Collection System with Persona PLUS technology. Persona PLUS represents the next generation of Haemonetics’ proprietary and patented Persona technology that tailors plasma collections to each donor for improved average plasma volume per donation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAE: